Abstract: In order to create a cover for a battery module or for a battery store that comprises a plurality of battery cells, said cover serving not only as contact protection or as protection from the ingress of particles, but also fulfilling the function of a propagation protection by means of which a propagation of a thermal fault from one battery cell of the battery module or the battery store to other battery cells of the battery module or the battery store is able to be prevented or at least delayed, it is proposed that the cover comprises a first layer facing toward the battery cells in the mounted state of the cover and a second layer facing away from the battery cells in the mounted state of the cover, wherein the first layer comprises at least one penetration device, which enables a passage of hot gas from a battery cell through the first layer at a penetration point, and wherein the gas that has passed through the first layer is able to be dissipated from the penetration point in an interspace between the fi

Abstract: A method for determining a nonlinearity characteristic of a receiver path includes generating a set of N×M digital samples by repeating N times selecting an scaling factor from a set of N scaling factors, generating a version of a test signal, the version of the test signal corresponding to a test signal scaled by the respective scaling factor, processing the respective version of the test signal in at least a part of the receiver path to generate a respective processed signal, and storing M digital samples corresponding to the respective processed signal. Fourier-transformed data are generated using at least a portion of the set of N×M digital samples and a nonlinearity characteristic of the receiver path is determined based on the Fourier-transformed data.

Abstract: The present invention relates to a satellite communications system comprising a satellite with a spatial digital modulator for transmitting an incoming bit stream in multiple beams, wherein the spatial digital modulator is configured to generate transmit symbols by dividing the incoming bit stream into symbols of a symbol alphabet and to allocate each transmit symbol to a specific beam. The invention further relates to a method for transmitting a bit stream by such a satellite communications system.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as preterm labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: A main switch of an electrical system of a vehicle, in particular agricultural machinery, with a first main current path in which a first switch is introduced, and with a second main current path. The main switch comprises a control unit and the first main current path is associated with a first current sensor and the second main current path is associated with a second current sensor. By means of the control unit, the first switch is actuated as a function of a deviation from the electrical currents detected by the two current sensors.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as preterm labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: The present invention relates to a process for preparing 1,4-butanediol (BDO) by hydrogenating 2-butyne-1,4-diol (BYD) or 4-hydroxybutanal (4-HBA) in the presence of a catalyst of the Raney type having a porous foam structure, wherein the macroscopic pores have sizes in the range of 100 to 5000 ?m, and a bulk density of up to 0.8 kg/L.

Abstract: A method for traffic monitoring for a monitoring location. The method has a step of outputting a display signal to a user interface. The display signal displays at least one image symbol, relating to at least one configurable parameter of the traffic monitoring, in a combined overview for the monitoring location via the user interface. The at least one image symbol can be influenced by gestural interaction with a user in order to configure the at least one configurable parameter. The method also includes reading in a user input signal from the user interface. The user input signal represents an input by the user, made by gestural interaction with the at least one image symbol and recognized by gesture recognition, to configure the at least one parameter. The method configures the at least one configurable parameter depending on the user input signal in order to set up traffic monitoring.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: The present invention provides 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors, in which R1 to R3 and ‘m’ have the meanings given in the specification, and pharmaceutically acceptable salts or stereoisomer thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting DHODH. The present invention also provides methods for synthesizing 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives of formula (I). The present invention also provides pharmaceutical formulations comprising at least one of the DHODH inhibitor compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as preterm labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: The present invention provides 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors, in which R1 to R3 and ‘m’ have the meanings given in the specification, and pharmaceutically acceptable salts or stereoisomer thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting DHODH. The present invention also provides methods for synthesizing 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives of formula (I). The present invention also provides pharmaceutical formulations comprising at least one of the DHODH inhibitor compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient.

Abstract: The invention provides pharmaceutical compositions comprising a compound of formula (I) or (II) and an additional therapeutic agent Also provided is the HCI salt and crystalline form of the compound of formula (I). The compounds inhibit the prostaglandin F receptor (PGF2alpha) and thus useful in the treatment of disorders such as preterm labor at the early gestational stage.

Abstract: The present invention relates to a process for preparing 1,4-butanediol (BDO) by hydrogenating 2-butyne-1,4-diol (BYD) or 4-hydroxybutanal (4-HBA) in the presence of a catalyst of the Raney type having a porous foam structure, wherein the macroscopic pores have sizes in the range of 100 to 5000 ?m, and a bulk density of up to 0.8 kg/L.

Abstract: A power relay for a vehicle is disclosed. The power relay has a housing formed by a connector base and a housing can set thereon, two connection bolts being inserted into the connector base for contacting a load circuit. The power relay further has a coil subassembly arranged in the housing and containing a solenoid coil and an armature. The armature is coupled by a force-transmission member to a contact bridge and can shift in the housing, under the effect of a magnetic field generated by the solenoid coil, in such a way that the contact bridge can be reversibly moved between a closing position, in which the contact bridge bridges the connection bolts in an electro conducting manner, and an opening position, in which the contact bridge is not in contact with the connection bolts. The housing can is configured as an injection-molded component made of plastic.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.

Abstract: A power relay for a vehicle, in particular a utility vehicle, is disclosed. The power relay contains a housing formed by a connecting base and a housing pot that is placed on the connecting base. Accordingly, two connecting bolts for establishing contact with an on-load circuit are formed by standard screws.

Abstract: The invention provides pharmaceutical compositions comprising a compound of formula (I) or (II) and an additional therapeutic agent Also provided is the HCI salt and crystalline form of the compound of formula (I). The compounds inhibit the prostaglandin F receptor (PGF2alpha) and thus useful in the treatment of disorders such as preterm labor at the early gestational stage.

Abstract: A high current switch, in particular for a motor vehicle, having a first bus bar, a second bus bar in addition to a first semi-conductor switch that has a control connection and a first transmission connection as well as a second transmission connection. The first transmission connection is placed in direct contact with the first bus bar and the second transmission connection is placed in direct electric contact with the second bus bar.